Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk (M1)
April 12-15, 2026
| Fairmont Hotel Vancouver, Vancouver, BC, Canada
Utpal B. Pajvani, Jennifer L. Estall and Ariel E. Feldstein
Scholarship Deadline: Dec. 10, 2025 | Abstract Deadline: Mar. 20, 2026 | Early Registration Deadline: Feb. 12, 2026
| 4:00–8:00 PM |
Registration |
British/Columbia Foyer |
| 6:00–8:00 PM |
Welcome Mixer |
British/Columbia Foyer |
| 7:30–8:30 AM |
Breakfast |
Vancouver Island Room |
| 8:30–10:00 AM |
Welcome and Keynote Session |
Columbia Ballroom |
| |
Linda G. Griffith, Massachusetts Institute of Technology
Humanizing Drug Discovery: Microphysiological Systems to Model MASH |
|
| |
Rohit Loomba, University of California, San Diego, Salk Institute
Translational Update on MASH |
|
| 10:00–10:20 AM |
Coffee Break |
British/Columbia Foyer |
| 10:20–11:45 AM |
Mechanisms of Hepatocyte Metabolic Dysfunction in Obesity |
Columbia Ballroom |
| |
Rotonya Carr, University of Washington
Unraveling the Role of Lipid Droplet Proteins in MASLD |
|
| |
Mark A Herman, Baylor College of Medicine
Carbohydrate Metabolism and Steatosis, Intersection of Hepatokines and Metabolism |
|
| |
Jennifer L. Estall, Institut de Recherches Cliniques de Montréal
Understanding the Fasting Response in Hepatic Lipid Metabolism |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 11:45–1:00 PM |
Poster Setup |
British/Columbia Ballroom |
| 11:45–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
British/Columbia Ballroom |
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
Columbia Ballroom |
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
British/Columbia Foyer |
| 5:00–7:00 PM |
Endocrine Regulators of Hepatocyte Metabolic Functions |
Columbia Ballroom |
| |
Magdalene K. Montgomery, University of Melbourne
Using Genome-Wide CRISPR Screens to Identify Novel Regulators of Hepatic Lipid Metabolism in MASH |
|
| |
Kristina Schoonjans, École Polytechnique Fédérale de Lausanne – EPFL
Gut-Liver Axis |
|
| |
Timothy P. Rolph, Akero Therapeutics
FGFs in MASH Pathogenesis and Therapy |
|
| |
Filip K. Knop, Gentofte Hospital, University of Copenhagen
Role of Glucagon and Incretins in MASH |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
Vancouver Island Room |
| 7:30–10:00 PM |
Poster Session 1 |
British/Columbia Ballroom |
| 7:30–8:30 AM |
Breakfast |
Vancouver Island Room |
| 8:00–8:30 AM |
Poster Setup |
British/Columbia Ballroom |
| 8:15–5:00 PM |
Poster Viewing |
British/Columbia Ballroom |
| 8:30–11:30 AM |
Intercellular and Interorgan Crosstalk in Development of Liver Disease |
Columbia Ballroom |
| |
Xingxing Kong, Fudan University
Adipose-Muscle-Liver Crosstalk |
|
| |
Ruchi Bansal, University of Twente
Single-Cell Phenomics and EV-Omics to Unravel Cellular and Organ Crosstalk in MASH and Liver Cancer |
|
| |
Ornella Barrandon, Cellarity
Revealing Novel MASH Biology at Single Cell Resolution |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
British/Columbia Foyer |
| 11:30–12:30 PM |
Lunch |
Vancouver Island Room |
| 12:00–2:30 PM |
Poster Session 2 |
British/Columbia Ballroom |
| 3:00–4:30 PM |
Career Roundtable |
British Ballroom |
| 4:30–5:00 PM |
Coffee Available |
British/Columbia Foyer |
| 5:00–7:00 PM |
Intrahepatic Determinants of Liver Inflammation and Fibrosis in MASH |
Columbia Ballroom |
| |
Utpal B. Pajvani, Columbia University Medical Center
Adipogenic Reprogramming of Hepatocytes as a Contributor to Fibrosis |
|
| |
Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ
Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk |
|
| |
Ariel E. Feldstein, University of California, San Diego & Novo Nordisk
Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
On Own for Dinner |
|
Wednesday, April 15, 2026
| 7:30–8:30 AM |
Breakfast |
Vancouver Island Room |
| 8:30–11:30 AM |
Mechanisms of Liver Regeneration and Progression to HCC |
Columbia Ballroom |
| |
Hao Zhu, University of Texas Southwestern Medical Center
Somatic Mutations in MASH Progression |
|
| |
Robert F. Schwabe, Columbia University
Regulation of Hepatocyte Metabolism by Hepatic Stellate Cells in MASH: Looking Beyond Fibrogenesis |
|
| |
KyeongJin Kim, Inha University
Mechanisms of MASH-Induced HCC |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
British/Columbia Foyer |
| 11:30–5:00 PM |
On Own for Lunch |
|
| 1:00–2:00 PM |
Panel: Perspectives: Personalized Medicine and Patient-Centered Strategies (joint) |
Columbia Ballroom |
| 2:30–4:30 PM |
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
Columbia Ballroom |
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
British/Columbia Foyer |
| 5:00–6:45 PM |
Emerging Translational Approaches to MASH |
Columbia Ballroom |
| |
Simon J Cockell, University of Newcastle upon Tyne
Proteo-Transcriptomic Profiles in MASLD |
|
| |
Diana Julie Leeming, Nordic Bioscience
Circulating Markers of Extracellular Matrix for MASLD Risk Stratification and Prediction of Response to Therapy |
|
| |
Katy Wack, PathAI
Bringing Precision to Pathologic Assessment for MASH: Clinical Validation of an AI-based Drug Development Tool |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
Columbia Ballroom |
| 7:00–8:00 PM |
Social Hour with Dinner |
Vancouver Island Room |
| 8:00–11:00 PM |
Entertainment |
|
